| Dr Eric Lee Ellis, MD | |
|
77 Lincoln Blvd Ste 1, Lincoln, CA 95648-7422 | |
| (916) 258-2751 | |
| (916) 258-7172 |
| Full Name | Dr Eric Lee Ellis |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 23 Years |
| Location | 77 Lincoln Blvd Ste 1, Lincoln, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215968409 | NPI | - | NPPES |
| CA333419 | Other | CA | MC PIN |
| 00A863170 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A86317 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sutter Roseville Medical Center | Roseville, CA | Hospital |
| Sutter Medical Center, Sacramento | Sacramento, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eric L Ellis Md Inc | 9032458815 | 13 |
News Archive
Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.
LogLogic®, the leader in log and security management solutions, and the Ponemon Institute, a privacy and information management research firm, today announced results of a national survey of healthcare IT security professionals that shows patients may be surrendering their privacy as the $2.5 trillion medical industry – prompted by federal stimulus funding – pushes to accelerate the pace of digitizing health information records.
Lower rates of sudden death among women may be related to gender differences in heart arrhythmias, rather than to other heart disease factors or treatments, hypertension, diabetes or other measured variables, according to a new study in the June 16, 2004 issue of the Journal of the American College of Cardiology.
An exciting new study published in the journal Nature Biomedical Engineering in April 2020 reports excellent results with a new test for two common viruses that infect kidney transplant patients. The levels of these viruses shoot up during the acute phase of rejection.
Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.
› Verified 1 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.
LogLogic®, the leader in log and security management solutions, and the Ponemon Institute, a privacy and information management research firm, today announced results of a national survey of healthcare IT security professionals that shows patients may be surrendering their privacy as the $2.5 trillion medical industry – prompted by federal stimulus funding – pushes to accelerate the pace of digitizing health information records.
Lower rates of sudden death among women may be related to gender differences in heart arrhythmias, rather than to other heart disease factors or treatments, hypertension, diabetes or other measured variables, according to a new study in the June 16, 2004 issue of the Journal of the American College of Cardiology.
An exciting new study published in the journal Nature Biomedical Engineering in April 2020 reports excellent results with a new test for two common viruses that infect kidney transplant patients. The levels of these viruses shoot up during the acute phase of rejection.
Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.
› Verified 1 days ago
| Entity Name | Mmc Emergency Physicians Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285670406 PECOS PAC ID: 7911809215 Enrollment ID: O20040927001225 |
News Archive
Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.
LogLogic®, the leader in log and security management solutions, and the Ponemon Institute, a privacy and information management research firm, today announced results of a national survey of healthcare IT security professionals that shows patients may be surrendering their privacy as the $2.5 trillion medical industry – prompted by federal stimulus funding – pushes to accelerate the pace of digitizing health information records.
Lower rates of sudden death among women may be related to gender differences in heart arrhythmias, rather than to other heart disease factors or treatments, hypertension, diabetes or other measured variables, according to a new study in the June 16, 2004 issue of the Journal of the American College of Cardiology.
An exciting new study published in the journal Nature Biomedical Engineering in April 2020 reports excellent results with a new test for two common viruses that infect kidney transplant patients. The levels of these viruses shoot up during the acute phase of rejection.
Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.
› Verified 1 days ago
| Entity Name | Chico Emergency Physicians Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578598058 PECOS PAC ID: 0345277349 Enrollment ID: O20050721000294 |
News Archive
Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.
LogLogic®, the leader in log and security management solutions, and the Ponemon Institute, a privacy and information management research firm, today announced results of a national survey of healthcare IT security professionals that shows patients may be surrendering their privacy as the $2.5 trillion medical industry – prompted by federal stimulus funding – pushes to accelerate the pace of digitizing health information records.
Lower rates of sudden death among women may be related to gender differences in heart arrhythmias, rather than to other heart disease factors or treatments, hypertension, diabetes or other measured variables, according to a new study in the June 16, 2004 issue of the Journal of the American College of Cardiology.
An exciting new study published in the journal Nature Biomedical Engineering in April 2020 reports excellent results with a new test for two common viruses that infect kidney transplant patients. The levels of these viruses shoot up during the acute phase of rejection.
Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.
› Verified 1 days ago
| Entity Name | Glenn Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1336187178 PECOS PAC ID: 3870505035 Enrollment ID: O20070705000269 |
News Archive
Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.
LogLogic®, the leader in log and security management solutions, and the Ponemon Institute, a privacy and information management research firm, today announced results of a national survey of healthcare IT security professionals that shows patients may be surrendering their privacy as the $2.5 trillion medical industry – prompted by federal stimulus funding – pushes to accelerate the pace of digitizing health information records.
Lower rates of sudden death among women may be related to gender differences in heart arrhythmias, rather than to other heart disease factors or treatments, hypertension, diabetes or other measured variables, according to a new study in the June 16, 2004 issue of the Journal of the American College of Cardiology.
An exciting new study published in the journal Nature Biomedical Engineering in April 2020 reports excellent results with a new test for two common viruses that infect kidney transplant patients. The levels of these viruses shoot up during the acute phase of rejection.
Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.
› Verified 1 days ago
| Entity Name | Pinnacle Emergency Physicians Of Bakersfield, A Professional Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619153251 PECOS PAC ID: 7214086321 Enrollment ID: O20090520000375 |
News Archive
Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.
LogLogic®, the leader in log and security management solutions, and the Ponemon Institute, a privacy and information management research firm, today announced results of a national survey of healthcare IT security professionals that shows patients may be surrendering their privacy as the $2.5 trillion medical industry – prompted by federal stimulus funding – pushes to accelerate the pace of digitizing health information records.
Lower rates of sudden death among women may be related to gender differences in heart arrhythmias, rather than to other heart disease factors or treatments, hypertension, diabetes or other measured variables, according to a new study in the June 16, 2004 issue of the Journal of the American College of Cardiology.
An exciting new study published in the journal Nature Biomedical Engineering in April 2020 reports excellent results with a new test for two common viruses that infect kidney transplant patients. The levels of these viruses shoot up during the acute phase of rejection.
Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.
› Verified 1 days ago
| Entity Name | Acute Medical Providers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942571146 PECOS PAC ID: 1153589874 Enrollment ID: O20120225000135 |
News Archive
Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.
LogLogic®, the leader in log and security management solutions, and the Ponemon Institute, a privacy and information management research firm, today announced results of a national survey of healthcare IT security professionals that shows patients may be surrendering their privacy as the $2.5 trillion medical industry – prompted by federal stimulus funding – pushes to accelerate the pace of digitizing health information records.
Lower rates of sudden death among women may be related to gender differences in heart arrhythmias, rather than to other heart disease factors or treatments, hypertension, diabetes or other measured variables, according to a new study in the June 16, 2004 issue of the Journal of the American College of Cardiology.
An exciting new study published in the journal Nature Biomedical Engineering in April 2020 reports excellent results with a new test for two common viruses that infect kidney transplant patients. The levels of these viruses shoot up during the acute phase of rejection.
Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.
› Verified 1 days ago
| Entity Name | Eric L Ellis Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386118305 PECOS PAC ID: 9032458815 Enrollment ID: O20190222002332 |
News Archive
Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.
LogLogic®, the leader in log and security management solutions, and the Ponemon Institute, a privacy and information management research firm, today announced results of a national survey of healthcare IT security professionals that shows patients may be surrendering their privacy as the $2.5 trillion medical industry – prompted by federal stimulus funding – pushes to accelerate the pace of digitizing health information records.
Lower rates of sudden death among women may be related to gender differences in heart arrhythmias, rather than to other heart disease factors or treatments, hypertension, diabetes or other measured variables, according to a new study in the June 16, 2004 issue of the Journal of the American College of Cardiology.
An exciting new study published in the journal Nature Biomedical Engineering in April 2020 reports excellent results with a new test for two common viruses that infect kidney transplant patients. The levels of these viruses shoot up during the acute phase of rejection.
Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric Lee Ellis, MD 77 Lincoln Blvd Ste 1, Lincoln, CA 95648-7422 Ph: (916) 258-2751 | Dr Eric Lee Ellis, MD 77 Lincoln Blvd Ste 1, Lincoln, CA 95648-7422 Ph: (916) 258-2751 |
News Archive
Santarus, Inc., S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize CYCLOSET (bromocriptine mesylate) tablets in the U.S.
LogLogic®, the leader in log and security management solutions, and the Ponemon Institute, a privacy and information management research firm, today announced results of a national survey of healthcare IT security professionals that shows patients may be surrendering their privacy as the $2.5 trillion medical industry – prompted by federal stimulus funding – pushes to accelerate the pace of digitizing health information records.
Lower rates of sudden death among women may be related to gender differences in heart arrhythmias, rather than to other heart disease factors or treatments, hypertension, diabetes or other measured variables, according to a new study in the June 16, 2004 issue of the Journal of the American College of Cardiology.
An exciting new study published in the journal Nature Biomedical Engineering in April 2020 reports excellent results with a new test for two common viruses that infect kidney transplant patients. The levels of these viruses shoot up during the acute phase of rejection.
Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.
› Verified 1 days ago